Copyright Reports & Markets. All rights reserved.

Europe Plasma Protein Therapeutics Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Plasma Protein Therapeutics Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Coagulation Factors Market Performance (Volume)
      • 2.1.2 Immunoglobulins Market Performance (Volume)
      • 2.1.3 Albumins Market Performance (Volume)
      • 2.1.4 C1 esterase Inhibitors Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Coagulation Factors Market Performance (Value)
      • 2.1.2 Immunoglobulins Market Performance (Value)
      • 2.1.3 Albumins Market Performance (Value)
      • 2.1.4 C1 esterase Inhibitors Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hemophilia Market Performance (Volume)
      • 3.1.2 Primary Immunodeficiency Disorder Market Performance (Volume)
      • 3.1.3 Idiopathic Thrombocytopenic Purpura Market Performance (Volume)
      • 3.1.4 Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids) Market Performance (Volume)
      • 3.1.5 Hereditary Angioedema Market Performance (Volume)
      • 3.1.6 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Baxter International
      • 4.1.1 Baxter International Profiles
      • 4.1.2 Baxter International Product Information
      • 4.1.3 Baxter International Plasma Protein Therapeutics Business Performance
      • 4.1.4 Baxter International Plasma Protein Therapeutics Business Development and Market Status
    • 4.2 Biotest?
      • 4.2.1 Biotest? Profiles
      • 4.2.2 Biotest? Product Information
      • 4.2.3 Biotest? Plasma Protein Therapeutics Business Performance
      • 4.2.4 Biotest? Plasma Protein Therapeutics Business Development and Market Status
    • 4.3 CSL Behring
      • 4.3.1 CSL Behring Profiles
      • 4.3.2 CSL Behring Product Information
      • 4.3.3 CSL Behring Plasma Protein Therapeutics Business Performance
      • 4.3.4 CSL Behring Plasma Protein Therapeutics Business Development and Market Status
    • 4.4 China Biologics
      • 4.4.1 China Biologics Profiles
      • 4.4.2 China Biologics Product Information
      • 4.4.3 China Biologics Plasma Protein Therapeutics Business Performance
      • 4.4.4 China Biologics Plasma Protein Therapeutics Business Development and Market Status
    • 4.5 GRIFOLS, S.A.
      • 4.5.1 GRIFOLS, S.A. Profiles
      • 4.5.2 GRIFOLS, S.A. Product Information
      • 4.5.3 GRIFOLS, S.A. Plasma Protein Therapeutics Business Performance
      • 4.5.4 GRIFOLS, S.A. Plasma Protein Therapeutics Business Development and Market Status
    • 4.6 Kedrion
      • 4.6.1 Kedrion Profiles
      • 4.6.2 Kedrion Product Information
      • 4.6.3 Kedrion Plasma Protein Therapeutics Business Performance
      • 4.6.4 Kedrion Plasma Protein Therapeutics Business Development and Market Status
    • 4.7 Octapharma USA, Inc.
      • 4.7.1 Octapharma USA, Inc. Profiles
      • 4.7.2 Octapharma USA, Inc. Product Information
      • 4.7.3 Octapharma USA, Inc. Plasma Protein Therapeutics Business Performance
      • 4.7.4 Octapharma USA, Inc. Plasma Protein Therapeutics Business Development and Market Status
    • 4.8 Shire Plc.
      • 4.8.1 Shire Plc. Profiles
      • 4.8.2 Shire Plc. Product Information
      • 4.8.3 Shire Plc. Plasma Protein Therapeutics Business Performance
      • 4.8.4 Shire Plc. Plasma Protein Therapeutics Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Plasma Protein Therapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Plasma Protein Therapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Plasma Protein Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Plasma Protein Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Plasma Protein Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Plasma Protein Therapeutics Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Plasma Protein Therapeutics Market Performance (Sales Point)

    • 7.1 Europe Plasma Protein Therapeutics Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Plasma Protein Therapeutics Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Plasma Protein Therapeutics Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Plasma Protein Therapeutics Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Plasma Protein Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hemophilia Industry
    • 11.2 Primary Immunodeficiency Disorder Industry
    • 11.3 Idiopathic Thrombocytopenic Purpura Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Plasma Protein Therapeutics Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Plasma Protein Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Coagulation Factors Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Immunoglobulins Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Albumins Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 C1 esterase Inhibitors Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hemophilia Sales and and Growth Rate 2019-2024
      • 12.4.3 Primary Immunodeficiency Disorder Sales and and Growth Rate 2019-2024
      • 12.4.4 Idiopathic Thrombocytopenic Purpura Sales and and Growth Rate 2019-2024
      • 12.4.5 Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids) Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Plasma Protein Therapeutics Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Plasma Protein Therapeutics Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Plasma Protein Therapeutics for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Plasma Protein Therapeutics market competition by top manufacturers/players, with Plasma Protein Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Baxter International
    Biotest?
    CSL Behring
    China Biologics
    GRIFOLS, S.A.
    Kedrion
    Octapharma USA, Inc.
    Shire Plc.

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Coagulation Factors
    Immunoglobulins
    Albumins
    C1 esterase Inhibitors

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Plasma Protein Therapeutics for each application, including
    Hemophilia
    Primary Immunodeficiency Disorder
    Idiopathic Thrombocytopenic Purpura
    Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids)
    Hereditary Angioedema
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now